Date: Wednesday, December 19th, 2018
Stock(s) mentioned: BLUE
Source: Motley Fool (https://www.fool.com)
Summary: In recent years, bluebird bio (NASDAQ:BLUE) has excited the medical community with terrific results for experimental therapies. Deep-pocketed biotechs and …
Full article address: https://www.fool.com/investing/2018/12/19/forget-bluebird-bio-amgen-is-a-better-biotech-stoc.aspx
Related News:
$ALXN $ABBV $AIMT $BLUE: Top 5 New Drug Launches of 2019 — and the Biotech Stocks That …
$BLUE: bluebird bio to Present New Data from Clinical Studies of …
$BLUE $IBB: Bluebird Bio Shares Fall Over Analysts’ Concerns On Pricing Model
$BLUE: Downgrades rule in premarket analyst action
$BLUE: bluebird bio’s Analyst Day Highlights Commercial Path to Patients …
$BLUE: bluebird bio Flies Forward
$BLUE $CELG $REGN: bluebird’s (BLUE) Loss Wider Than Expected, Revenues Down Y/Y
$CELG $BLUE: Celgene Corporation and bluebird bio Announce Results from …
$BLUE: bluebird bio Appoints Joanne Smith-Farrell, Ph.D., to Chief Business …
$BLUE $ADRO $HUM $WCG: Is a Beat in Store for WellCare Health’s (WCG) Q1 Earnings?
$BLUE $ADRO $HUM $HCA: What’s in Store for HCA Healthcare’s (HCA) Q1 Earnings?
Latest News:
$FB: Facebook, Winklevoss held crypto talks
$VNE: Veoneer Recognized by General Motors as a 2018 Supplier of the …
$MA: Mastercard Adds World Number One Tennis Player Naomi Osaka to …
$ECH: Chile Macro Update May 2019: Softer Growth Weighing On Equities
$STM: STMicroelectronics Joins Car Connectivity Consortium
$DIS $NFLX: 3 Reasons Why Disney Stock Could Avoid Becoming A Trade War …
$CSCO $NOK: Cisco Stock Investors Will Keep Winning As The Trade War Heats Up
$GM: Veoneer Recognized by General Motors as a 2018 Supplier of the …
